by EPHA | Jun 1, 2008 | Opinion
European antitrust investigators are expanding the scope of a major inquiry into the €484 billion pharmaceutical market in a bid to determine whether companies are blocking generics makers from getting less-expensive medicines to market quickly. Neelie Kroes, the...
